This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Nippi Corporation, The University of Tokyo. Active years: 2018.
Company Filing History:

Years Active: 2018
Title: Naoko Teramura - Innovator in Recombinant Collagenase Technology
Introduction
Naoko Teramura, located in Tokyo, Japan, is an accomplished inventor recognized for her significant contributions to the field of biochemistry. With one patent to her name, Teramura has made notable advancements in the development of recombinant collagenases that have valuable applications in cell and tissue dissociation.
Latest Patents
Teramura's sole patent focuses on recombinant collagenases characterized by a stable specific activity. This innovative enzyme agent is notable for its unique structure, featuring a collagenase catalytic domain, a linker region sequence, and a specific prepeptidase C terminal domain. The recombinant collagenase derived from this invention demonstrates high and stable specific activity, making it an essential tool for various biochemical applications.
Career Highlights
Throughout her career, Naoko Teramura has worked with esteemed organizations, including Nippi Corporation and The University of Tokyo. Her experiences in these reputed institutions have equipped her with the knowledge and skills necessary to excel in her research and innovation pursuits.
Collaborations
Teramura has collaborated with notable colleagues in her field, including Katsumasa Iijima and Osamu Hayashida. These collaborative efforts have enriched her research and have contributed to the further development of innovative solutions in biochemistry.
Conclusion
Naoko Teramura's work in the field of recombinant collagenases exemplifies her commitment to advancing scientific knowledge and innovation. Her patented invention not only showcases her ingenuity but also has the potential to impact various industries reliant on tissue and cell dissociation processes. With her ongoing contributions, Teramura remains a prominent figure in biochemistry and innovation.